Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Carcinoma, Renal Cell 73Neoplasm Metastasis 30Kidney Neoplasms 26Neoplasms 19Breast Neoplasms 14Prostatic Neoplasms 12Urinary Bladder Neoplasms 10Melanoma 9Gastrointestinal Stromal Tumors 9Brain Neoplasms 9Glioblastoma 8Sarcoma 7Carcinoma, Non-Small-Cell Lung 7Liver Neoplasms 6Carcinoma, Hepatocellular 6Recurrence 5Pancreatic Neoplasms 5Ovarian Neoplasms 5Esophageal Neoplasms 5Colorectal Neoplasms 5Thyroid Neoplasms 4Solid Tumors 4Osteosarcoma 4Lung Neoplasms 4Leukemia, Myeloid, Acute 4Adenocarcinoma 4Uveal Melanoma 3Thymoma 3Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Gemcitabine 3130-nm albumin-bound paclitaxel 3Blood Specimen Collection 2Albumin-Bound Paclitaxel 2sonidegib 1parecoxib 1lutetium Lu 177 dotatate 1copper dotatate CU-64 1Surveys and Questionnaires 1Sunitinib 1Rehabilitation 1Postoperative Care 1Piperacillin, Tazobactam Drug Combination 1Needles 1Methods 1Lutetium-177 1Lutetium 1Irinotecan 1Histocompatibility Testing 1HhAntag691 1Duodenoscopes 1Drainage 1Cisplatin 1Cefoxitin 1Capecitabine 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Diseases × Sunitinib × Clear all
NCT01215578 2015-04-30

NET

Assistance Publique - Hôpitaux de Paris

Phase 2 Terminated
33 enrolled
EndocrineGastrointestinalNET

Adenocarcinoma, Adenoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Pancreatic Diseases, Pancreatic Neoplasms, Neuroectodermal Tumors, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡